IL-17 targeting small molecule therapeutics (Sanofi)

N/A

Report date: 2025/06/11 10:25:56
NME

Base Information

Drug NameIL-17 targeting small molecule therapeutics (Sanofi)
Drug Alias NameIL-17A targeting small molecule therapeutics (Sanofi)IL-17 targeting small molecule therapeutics (C4X Discovery Holding)
ClassificationSmall molecules
Mechanisms of ActionInterleukin-17 inhibitors
TargetsInterleukin-17
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesC4X Discovery Holdings plc
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesC4X Discovery Holdings plc
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A